It's a blind trial, so no one will know officially until the last patient has completed 24 weeks, plus a few months to compile the results. But can Big Pharma wait that long ?? Particularly if the Mortality rate is lower than would normally be expected ?
As far as being repurposed, the Safety margin for Monepantel is pretty well established already.
I think the OLE and the pre clinical results for Parkinsons and Alzhimers may have a greater impact than many realize. Also have a deep look at our Scientific Advisory Board. It really is the dream team, also why did Healey and Berry choose our P 1/2 results to present an ENCALS When they had already trialed 7 other drugs on their platform ?
Fingers crossed.
- Forums
- ASX - By Stock
- PAA
- Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$, page-286
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
17.0¢ |
Change
-0.003(1.45%) |
Mkt cap ! $85.12M |
Open | High | Low | Value | Volume |
17.0¢ | 17.5¢ | 17.0¢ | $80.76K | 474.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3976 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 218934 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3976 | 0.170 |
8 | 250238 | 0.165 |
10 | 403029 | 0.160 |
7 | 351734 | 0.155 |
7 | 215993 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 218934 | 5 |
0.180 | 177319 | 8 |
0.185 | 323104 | 5 |
0.190 | 753702 | 8 |
0.195 | 593409 | 10 |
Last trade - 14.04pm 16/09/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |